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Summary
Introduction Early genetic and environmental factors have been discussed as potential
causes for the high prevalence of asthma and allergic disease in the western world, and
knowledge on fetal growth and its consequence on future health and disease development
is emerging.
Objective This review article is an attempt to summarize research on fetal growth and risk
of asthma and allergic disease. Current knowledge and novel findings will be reviewed
and open research questions identified, to give basic scientists, immunologists and
clinicians an overview of an emerging research field.
Methods PubMed-search on pre-defined terms and cross-references.
Results Several studies have shown a correlation between low birth weight and/or gesta-
tional age and asthma and high birth weight and/or gestational age and atopy. The exact
mechanism is not yet clear but both environmental and genetic factors seem to contribute
to fetal growth. Some of these factors are confounders that can be adjusted for, and twin
studies have been very helpful in this context. Suggested mechanisms behind fetal growth
are often linked to the feto-maternal circulation, including the development of placenta
and umbilical cord. However, the causal link between fetal growth restriction and subse-
quent asthma and allergic disease remains unexplained. New research regarding the
catch-up growth following growth restriction has posited an alternative theory that dis-
eases later on in life result from rapid catch-up growth rather than intrauterine growth
restriction per se. Several studies have found a correlation between a rapid weight gain
after birth and development of asthma or wheezing in childhood.
Conclusion and clinical relevance Asthma and allergic disease are multifactorial. Several
mechanisms seem to influence their development. Additional studies are needed before we
fully understand the causal links between fetal growth and development of asthma and
allergic diseases.
Keywords allergic diseases, anthropometry, children, epigenetics, fetal growth, fetal
programming, infant, low birth weight, twin studies, wheezing
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Introduction
The prevalence of asthma and allergic disease has
increased in many nations around the world [1]. The
observed marked variation in prevalence between
genetically similar populations strongly implies that a
substantial proportion is attributable to environmental
aspects [2]. More than 100 genes are reportedly
associated with asthma [3] and a recent genome-wide
association study identified six genes with a strong and
consistent association, even though the diseases are
often influenced by gene–environment interactions [4].
Factors related to the hygiene hypothesis [5] have
revealed many previously unknown associations and
during the past decade the Barker hypothesis, which
states that restricted fetal growth may reflect insuffi-
cient energy supply for organ development and lead to
increased disease susceptibility later in life [6], has been
much discussed.
This area of research is quickly expanding and
several mechanisms have been proposed to influence
fetal growth. The aim of this article is therefore to
summarize current knowledge on fetal growth, and its
association to the development of asthma and allergic
disease, in order to identify the most urgent research
questions and their clinical implications.
Methods
A PubMed/Medline search was performed with the fol-
lowing MeSH-terms: [children OR child OR childhood]
AND [birthweight OR birth weight OR birth length OR
head circumference] AND [atopy OR asthma OR atopic
OR allergy] AND [fetal programming OR fetal growth]
and original articles identified and reviewed. Articles
that reported on birth characteristics or fetal growth
and asthma/allergic disease in the offspring, particularly
those published within the last 10 years, were included
and placed in sections related to subject; birth charac-
teristics and asthma/respiratory disease in the offspring,
birth characteristics and allergic disease in the off-
spring; mechanisms that influence fetal growth and
their association to asthma or allergic diseases, and
catch-up growth or post natal weight gain after fetal
growth restriction in association with asthma or respi-
ratory disease. Cross-references were reviewed and
additional articles were checked.
Results
The literature search identified 107 original articles, 29
of which were included in the article. Approximately
350 additional cross-references were reviewed and 24
of them were found relevant. Table 1 displays all these
articles. Articles excluded were those only reporting on
gestational age/children born prematurely, articles with
other main exposures or outcomes, and those published
more than 10 years ago. In addition, articles on mecha-
nisms that influence fetal growth and their association
to asthma or allergic diseases were assessed and
included in the review.
Several studies have looked at associations between
anthropometric measures (birth weight, birth length or
head circumference) and asthma or allergic diseases in
childhood or adolescence. Most studies have shown a
correlation between low birth weight [7–19] and/or
gestational age [20, 21] and asthma or decreased
lung function [10, 13, 22]. Fetal growth and birth
weight are not equivalent but a low birth weight can
be the result of an impaired fetal growth, or can be
due to other factors such as being prematurely born.
There is a strong correlation between gestational age
and birth weight and, as thoroughly reviewed by
Jaakkola et al., children born before 37 weeks of ges-
tation (= preterm) have an increased risk of asthma
[23] so our focus will be on birth anthropometry and
fetal growth.
Birth characteristics and asthma/respiratory disease in
the offspring
A prospective population-based study followed children
born in large American cities through maternal inter-
views at 1 and 3 years of age [15]. Children with low
birth weight had a higher prevalence of asthma than
normal weight children (34% vs. 18%). When adjusted
for several confounding risk factors, such as socio-eco-
nomic status, demographics and housing standard, as
well as prenatal medical risk factors and behaviours,
the risk remained virtually the same (adjusted OR 2.4,
P < 0.01).
A prospective birth cohort study in Finland found no
correlation between gestational age and asthma, but
children with a birth weight below 2,500 g had a higher
risk of asthma, 12% vs. 8% for those with a higher
birth weight [16]. The same results have been seen in
other studies [7, 9, 11].
In a retrospective population-based case-control
study by Walter et al., children born with a low birth
weight were more likely to have been hospitalized for
respiratory illnesses in adulthood than their normal
birth weight controls [19]. When compared to children
with normal birth weight, the OR was 1.8 (95% CI 1.3–
2.6) for children with a birth weight < 1500 g and 1.3
(95% CI 1.2–1.5) for those weighing 1500–2499 g.
In a prospective birth cohort study from Boston, chil-
dren born  36 weeks of gestation, who had one par-
ent with asthma, allergy or hayfever, were followed to
the age of 6 years [21]. At the first check-up at 1 year,
a correlation was found between low birth weight and
persistent wheeze. At the age of 6, the correlation was
reported between asthma and low-normal gestational
age ( 38.5 weeks) OR 4.7 (95% CI 2.1–10.5). Further-
more, the study showed that boys of low-normal gesta-
tional age were at eightfold greater risk of developing
asthma.
Some studies have found that the association
between low birth weight/gestational age and asthma/
respiratory illnesses seems to weaken with time [8, 24].
In the PIAMA prospective birth cohort study, children
born > 37 weeks of gestation were followed to 7 years
of age with annual questionnaires [8]. A low birth
weight was associated with symptoms of respiratory ill-
nesses, the OR for every 1000-g decrease in birth
weight was 1.2 (95% CI 1.1–1.3). However, these results
were significant only between the ages 1–5 years, and
by age 7, birth weight had no impact. It is possible that
the association only exists for a certain period after
birth and the effect of fetal growth disappears with age.
In line with this a retrospective follow-up study from
the United Kingdom collected birth records of 381 men
and women, 45–50 years old, and performed a lung
function test [24]. They found that low birth weight
© 2012 Blackwell Publishing Ltd, Clinical & Experimental Allergy, 42 : 1430–1447
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was associated with impaired lung function in terms of
forced expiratory volume in 1 s and forced vital capac-
ity, but not with current wheeze.
The associations between birth weight, postnatal
growth and adult lung function were assessed in an
unselected prospective birth cohort by Hancox et al.
[13]. Low birth weight correlated with impaired lung
function and lung diffusing capacity. These associations
persisted after adjustment for confounding factors
including adult weight, exposure to cigarette smoke in
utero and during childhood, personal smoking, socio-
economic status, asthma and gestational age. Children
with larger weight gain between birth and age 3 years
were more likely to have impaired lung diffusing
capacity, indicating that postnatal growth also has an
impact on adult lung function.
A prospective birth cohort study assessed the correla-
tion between low birth weight for gestational age and
lung function in infancy [10]. Children born after
35 weeks of gestation, without respiratory problems at
birth or prior to testing, with a birth weight assessed as
low or normal for gestational age were examined once
at 4–12 weeks of age with measures of weight, crown-
heel length, mid-arm, chest circumference and lung
function. After controlling for potential confounders,
low birth weight children were lighter and shorter than
the normal weight group at 6 weeks of age and had
lower flow and lung volume parameters.
In the Aberdeen birth cohort study, pregnant women
were recruited at a routine ultrasound during the first
trimester [22]. Fetal crown rump length (CRL) was mea-
sured in the first trimester, biparietal diameter in the
second trimester and the child completed a spirometric
test and a questionnaire at the age of five. The odds of
wheezing ever decreased by 4% (95% CI 1–7%;
P < 0.05) for each millimetre increase in CRL and the
odds of having asthma ever decreased by 5% (95% CI 1
–9%; P < 0.05), indicating that reduced fetal size in the
first and second trimester is associated with reduced
lung function and increased asthma symptoms at age
5 years. In the recently published 10-year follow-up of
the Aberdeen birth cohort, the associations between
fetal measurements and asthma remained [18]. Com-
pared to fetuses with high CRL at the first trimester and
high biparietal diameter in the second trimester (contin-
uous high growth), fetuses with low CRL and biparietal
diameter (continuous low growth) had a significant
higher risk of asthma and reduced lung function. The
study concludes that a continuous high fetal growth
rate seems to be a protective factor in the aspect of
future asthma development in young adults; OR 2.8
(95% CI 1.2–6.9).
Another group lead by Pike et al. studied fetal
growth during different periods in pregnancy in 1548
full-term children [25]. Birth weight and length wereTa
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measured at birth and growth rates were calculated
using the results from the antenatal ultrasound exami-
nation. The children were followed up to the age of
3 years. A low growth rate during week 11–19 was
associated with an increased risk for non-atopic wheeze
(10% per SD decrease) whereas a low growth rate later
on in pregnancy (week 19–34) seemed to be associated
with atopic wheeze (20% per SD decrease, P = 0,046).
Carrington et al. retrospectively collected information
from 7-year-old children, registered at two general
practitioners clinics in Northampton, United Kingdom,
through parental interviews and data extraction from
the Personal Child Record Book, a book used by mid-
wives in the United Kingdom at follow-up during
infancy [26]. Children born before 36 weeks of gesta-
tion were excluded. They found a correlation between a
small head circumference at day 10–15 after birth and
wheeze at the age of 7, but no association related to
head circumference at birth. These results are similar to
those of other studies [27, 28].
Although several studies have found positive associa-
tions between low birth weight and asthma, others have
not [24, 29, 30] and yet some have found the inverse;
a correlation between high birth weight and asthma
[31, 32].
Twin studies provide an excellent opportunity to
study the association between fetal growth and asthma,
controlling for shared (familial) environmental and
genetic factors. Twin siblings share genes (half if dizy-
gotic and all if monozygotic), intrauterine exposures,
maternal factors and early environment. In addition,
twins often differ in birth weight and body mass index
(BMI) over time [33]. Since twins have identical GA,
any difference in birth weight reflects factors that
affected the growth of each individual fetus. If associa-
tions seen in a cohort of twins remain in within-pair
(co-twin) analyses, then factors specific to each individ-
ual must be involved in the underlying causal path-
ways. Conversely, if the relationships disappear or
substantially diminish in within-pair analyses, then fac-
tors common to the pair must be involved. Comparison
of findings within monozygotic vs. within dizygotic
twin pairs (i.e., co-twin control analyses) may provide
insights into the role of genetic factors [34].
We have recently shown an increased risk of asthma
with a 1000-g decrease in birth weight, OR 1.6 (95% CI
1.4–1.8) [35]. A co-twin control analysis was made with
157 monozygotic twins and 289 dizygotic same-sex
twin pairs, where a 1000-g decrease in birth weight
resulted in an OR of 1.2 (95% CI 0.7–2.1) for the dizy-
gotic same-sex twins and OR 2.4 (95% CI 1.0–6.0) for
the monozygotic twins. As genetic and familial factors
could be excluded as confounders, these results
strengthen the association between childhood asthma
and birth weight, indicating that fetal growth restriction
might affect early metabolic or physiological mecha-
nisms in utero. Another twin study from Sweden on
adults [36] and a similar Danish study came to the same
conclusion [37].
Birth characteristics and allergic disease in the offspring
This area is not as explored as for asthma. Most studies
have found a positive correlation between gestational
age and atopy [16, 17, 27, 38, 39] although the correla-
tion between fetal size and eczema is contradictory
[18, 26].
A cross-sectional study reported a non-significant
positive correlation between birth weight, birth length
and gestational age and subsequent atopic sensitization
[38]. The levels of immunoglobulin E (IgE) were ele-
vated and the risk highest in those with a birth weight
over 4000 g (OR 1.8; 95% CI 0.8–4.1).
Pekkanen et al. followed children till the age of 31 in
a prospective birth cohort study [16] and found the risk
of atopy measured with skin prick test to increase with
increasing gestational age. Those born at or above GA
40 weeks had a 65% increased risk of atopy (OR 1.6;
95% CI 1.2–2.3) compared to children born before GA
36 weeks.
Whether or not fetal growth was associated with
asthma and atopic dermatitis was examined in a popu-
lation of male military conscripts in Denmark [17]. The
prevalence OR of atopic dermatitis among those with a
birth weight below 2501 g was 3.0 (95% CI 0.8–11.9)
compared with those with a birth weight 3001–3500 g.
Those with gestational age below 34 weeks had an
adjusted prevalence OR of 0.3 (95% CI 0.0–3.1) suggest-
ing fetal growth retardation rather than preterm deliv-
ery as the underlying gestational factor.
Katz et al. studied the presence of hayfever, asthma
and eczema in a large cohort of adolescents in Shef-
field, United Kingdom, by linking information on birth
characteristics to questionnaire data on present symp-
toms in 11-to-16-year-olds [27]. Hayfever was posi-
tively associated with anthropometric measurements
such as head circumference OR 1.2 (95% CI 1.0–1.5)
and birth weight OR 1.2 (95% CI 1.0–1.4), and also with
gestational age; children born before 37 weeks had
higher risk of hayfever and those with GA > 41 weeks
had lower risks, although not significant. No correlation
was found between anthropometric measures and
asthma or eczema. Carrington et al. drew the same con-
clusion regarding eczema [26] while Turner et al. found
a correlation between improved fetal size between first
and second trimester and a higher incidence of eczema
at the age of 10 years OR 2.5 (95% CI 1.2–5.3) [18].
In a twin study, we recently found a correlation
between birth weight and atopic eczema [40], with an
OR of 3.9 (95% CI 1.5–10.0) for a 500-g increase in
© 2012 Blackwell Publishing Ltd, Clinical & Experimental Allergy, 42 : 1430–1447
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birth weight, with no significant difference between
monozygotic and dizygotic twins (P = 0.84). These
results, combined with our previous findings of an
association between low birth weight and asthma [35],
indicate that fetus-specific mechanisms are involved in
the aetiology of asthma and atopic eczema.
Mechanisms that influence fetal growth and their
association to asthma or allergic diseases
Several mechanisms have been suggested to determine
fetal growth, most often related to the feto-maternal
circulation. Disturbances in the development of the pla-
centa and umbilical cord, on a genetic [41, 42], physio-
logical or anatomical level [43–46], inhibit the growth
and wellbeing of the fetus. Epigenetic mechanisms are
also believed to play a crucial role in the correct devel-
opment of placenta and fetus by affecting gene expres-
sion patterns [47, 48] as well as to play a role in the
future development of asthma and allergy [47, 49].
Although much is known about how these factors influ-
ence fetal growth, information on the exact mecha-
nisms underlying the association between fetal growth
and asthma and allergic disease is sparse. The separate
mechanisms are reviewed below, and illustrated in
Fig. 1.
Maternal factors. Several studies have shown an associ-
ation between offspring asthma and low socio-eco-
nomic status [50, 51], high maternal BMI [52, 53],
maternal smoking during pregnancy [14, 54], maternal
asthma [55, 56], maternal intake of paracetamol
[57, 58], exposure to antibiotics [59], maternal stress
during pregnancy [60], maternal intake of vitamin D
[61], vitamin E [22, 62], folic acid [63, 64], and omega-
3 polyunsaturated fatty acids [65, 66] during pregnancy
and mode of delivery [67–69]. Twin studies, however,
indicate that some of these exposures are rather con-
founders, since twins share maternal factors but can
still differ in size and incidence of asthma/atopic dis-
ease [35] (Fig. 1A).
Maternal smoking causes fetal growth retardation
[70]. Smoking might influence fetal growth to a differ-
ent extent during different phases of the pregnancy.
Prabhu et al. found an exposure-response relationship
between cigarettes smoked and fetal femur length in
the second and third trimester [54]. Maternal smoking
was associated with reduced fetal measurements in the
second and third trimester but not in the first trimester.
This confirms the researcher’s theory that if a pregnant
woman stops smoking in the first semester, the fetal
size at birth will be normal.
Previous studies have proposed that pregnancy could
be associated with a skewing of the immune system
from a Th1-type to Th2-type response at the maternal-
fetal interface. This skewing may be an essential factor
for implantation of the embryo as well as pregnancy
itself, by preventing a rejection of the antigenic fetus
by the mother’s cell-mediated response of Th1 cells
[71]. Allergic women are characterized by a predisposi-
tion to an enhanced Th2 deviation compared to
non-allergic women [72]. Based on this fact it has been
suggested that women with certain atopic phenotypes
may have a shorter time to pregnancy [73] and have
more successful pregnancy outcomes [74].
Placenta. Placental development begins when cyto-
trophoblast cells attach the embryo to the uterine wall
[75–77]. The cytotrophoblastic stem cells divide and
differentiate into extravillous trophoblastic cells and
syncytiotrophoblastic cells. The extravillous trophoblas-
tic cells migrate into the maternal tissue towards the
spiral arteries which are remodelled to become stronger
and wider, ensuring low resistance. The endovascular
trophoblastic cells gather into plugs in the end of the
spiral arteries and serve as a filter which prevents
maternal blood from flowing into the placenta but per-
mits oxygen supply to the fetus. Oxygenation gradually
increases, which stimulates fetal growth and up-regu-
lates several adhesion molecules that facilitate
additional trophoblast invasion.
Preeclampsia is a severe complication affecting 2–8%
of pregnancies world-wide [78, 79] and one of the lead-
ing causes of maternal mortality. It is defined as newly
arising hypertension (diastolic blood pressure  90 mm
Hg) and proteinuria ( 300 mg in 24 h) with an onset
at or after 20 weeks of gestation [80]. The only treatment
is delivery. The exact mechanisms underlying pre-
eclampsia are not yet known but one hypothesis is that
disturbed placentation during early pregnancy is fol-
lowed by release of toxic placental factors that lead to
endothelial dysfunction [75–77]. In preeclampsia the
trophoblastic invasion is shallow and the spiral arteries
are not remodelled properly. This leads to an inadequate
embryonic blood supply due to non-dilated vessels with
high resistance.
Altered levels of angiogenic factors are believed to
have an important role in the development of pre-
eclampsia [77]. In vitro and in vivo studies have shown
increasing levels of soluble fms-like tyrosine kinase 1
and soluble endoglin and a decrease in the level of vas-
cular endothelial growth factor and placental growth
factor. Dysfunctional endothelial cells release vasoactive
mediators which perturb haemodynamic function by
shifting the balance to vasoconstriction with decreased
organ perfusion, oedema and hypertension [77, 81].
Studies exploring the relationship between preeclampsia
and asthma and/or allergy development in the offspring
are scarce and have shown conflicting results [69, 82, 83]
(Fig. 1B).
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Fetal factors. For the fetus preeclampsia can result in
intrauterine growth restriction (IUGR) and preterm
delivery. IUGR affects about 3–5% of all pregnancies
and is believed to occur during the second half of preg-
nancy [45], although it may be present earlier. Thorsell
et al. investigated women with a discrepancy between
expected date of delivery calculated from last menstrual
period and due date according to ultrasound [84]. If the
expected due date calculated from ultrasound was
7 days later than the date calculated from last men-
strual period, the baby was twice as likely to be small
for gestational age (SGA) at birth, which is in line the
hypothesis that small fetal size in early pregnancy may
be a result of early growth restriction rather than short
gestational duration.
By measuring the uterine artery mean resistance
index with Doppler velocimetry during the first trimes-
ter, Dugoff et al. found that women with a high mean
resistance index had a fivefold higher risk of develop-
ing IUGR later in pregnancy (95% CI 1.6–8.7) [85]. This
may be a way of identifying patients at risk, who can
be followed more closely during the rest of the
pregnancy.
One group of children at risk for IUGR is twins and
especially monochoriotic twins. Several studies have
found that an unequal distribution of the placenta is a
major reason for differences in birth weight and selec-
tive IUGR in monochoriotic twin pregnancies [43, 86,
87]. This inequality could possibly be an effect of inter-
twin artery-to-artery anastomoses [88] (Fig. 1C).
In accordance with the finding that allergic disease is
associated with shorter waiting time to pregnancy
[73, 74], higher birth weight and less preterm births
[89, 90], it has also been suggested that the Th2-like
immunity associated with allergic disease could
promote a development of Th2 immune responses in
the offspring [91].
Research in fetal programming of subsequent disease
susceptibility is increasingly focusing on the paradigm
that gene regulation beyond the DNA-sequence – epige-
netic modulations – could play a key role in the aetio-
logical link between fetal growth and asthma and
allergic disease [49, 92, 93]. One type of epigenetic
mechanism, where gene expression is determined by a
functional inequality of expression between two paren-
tal alleles of a gene, is called imprinting. This type of
heredity is independent of the Mendelian inheritance,
meaning that genes are either expressed only from the
allele inherited from the mother, or from the allele
inherited from the father. Imprinting of genes has been
shown to be an important factor for proper placental
development and fetal growth [41, 42, 48, 94]. In gen-
eral, maternally imprinted genes have been shown to
restrict fetal growth, whereas paternally imprinted
genes enhance fetal growth. The hypothesis behind this
distribution of genetic impact is called the genetic con-
flict hypothesis, suggesting that paternally derived
genes influence the fetus to extract more nutrients and
energy from the mother for the survival of itself,
whereas the maternally derived genes have to balance
the energy supply between the current fetus and future
fetuses of the same mother. Consequently, the mater-
nally derived genes are more conservative in resource
provision [95]. Several imprinted genes interact with
the growth-controlling systems of insulin-like growth
factor and insulin, which in the fetus influence cell pro-
liferation and apoptosis, explaining their role in fetal
growth [42] (Fig. 1C).
The transformation of genotype into asthmatic and
atopic phenotypes may also be influenced by imprinted
genes, such that the predisposition to asthma and aller-
gic disease is present when transferred from the mother,
but silenced when transmitted by the father, making
maternal history of asthma and allergy more important
for the offspring’s subsequent morbidity [96]. Neverthe-
less, a recent study by Ferreira et al. showed that the
gene for the beta chain of the high affinity IgE receptor
was hyper-methylated in all children, independent of
their own and their parents’ atopic status, showing
how difficult it is to assign specific imprinted genes for
the inheritance of asthma and allergy [97], and for the
link between fetal growth and asthma and allergic
disease.
Umbilical cord. Fetal growth impairment is associated
not only with disturbances in the placenta, but also
with umbilical aberrations. In velamentous cord inser-
tion, the umbilical cord inserts into the fetal mem-
branes, unprotected by Wharton’s jelly (WJ), and then
travels within the membranes to the placenta instead of
inserting into the middle of the placenta as it develops
[98]. Studies have shown that velamentous cord inser-
tion is associated with impaired fetal growth both in
twins [43, 45] and in singletons [44]. One study has
suggested that hormonal and haemodynamic factors
that are released under conditions of reduced blood
flow could impair fetal growth in a setting of
velamentous cord insertion [99] (Fig. 1B and C).
Wharton’s Jelly is a gelatinous substance, normally
surrounding the umbilical cord, which helps resist
external pressure and serves as a physical buffer, regu-
lating the feto-placental circulation [100]. A recent
study found that if the amount of WJ increased, birth
weight also increased [101]. The authors suggest that
more WJ decreases the probability of cord compression,
positively affecting the blood and energy supply to the
fetus, thus increasing fetal growth. However, the exact
mechanisms behind the relationship between velamen-
tous cord insertion, WJ and impaired fetal growth are
incompletely understood (Fig. 1C).
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Umbilical cord cytokines are thought to play a key
role in regulating the maturation of the fetal immune
system, thus conditioning it for postnatal responses
against allergens and pathogens. Previous studies have
attempted to evaluate the relationship between umbili-
cal cord cytokines, fetal growth [102] and the develop-
ment of asthma and atopy later in life [103]. In one
study, higher concentrations of the pro-inflammatory
T-helper 1 cytokine interferon-c (IFN-c) in umbilical
cord blood were found to be associated with a
decreased risk of SGA birth [102] (Fig. 1C). The authors
suggest that this could indicate a more robust fetal
immune response that might arise from a larger and
better-nourished fetus, not excluding the possibility of
reverse causality, but they also suggest, conversely, that
low concentrations of IFN- c could be a biomarker of
placental insufficiency, which in turn could lead to
restricted fetal growth. The same study showed that
increased concentrations of the pro-inflammatory cyto-
kine tumour necrosis factor a (TNF) were associated
with increased risk of preterm delivery, which is not
analogous to fetal growth restriction, but can be closely
related. The authors here also point out that the results
could be an effect of reverse causality, and that the pre-
term delivery itself leads to higher concentrations of
the cytokines. Placental protein levels of IGF-1 and
IGFBP-1 are associated with IUGR and also appear to
be associated with maternal anthropometry [104, 105].
One study of umbilical cord cytokines and the risk of
asthma and allergic disease showed that higher concen-
trations of IFN- c were protective against asthma in
6-year-old children, but not against atopy, and that
higher concentrations of TNF were protective against
atopy, but not asthma [103]. Assuming that the associa-
tion between the exposure and outcome is linear, low
concentrations of IFN-c and TNF are associated with a
higher risk of asthma and atopy, respectively. These
results are in line with our previous findings that fetal
growth restriction was associated with an increased risk
of asthma [35] but a decreased risk of atopic eczema
[40] (Fig. 1D).
Thymus. The thymus is a key organ in the human
immune system and has long been known to be
affected by fetal growth restriction and postnatal mal-
nutrition [106]. This has led researchers to investigate if
malnutrition in utero, measured as restricted fetal
growth, can be linked to mismatched development of
thymus relative to immune function [107, 108]. Malnu-
trition leads to a ‘brain-sparing’ reflex, where blood is
redistributed to the brain to maintain oxygen supply,
which can result in the birth of a fetus with a dispro-
portionately large head [109]. Several studies have
shown an association between a large head circumfer-
ence at birth and increased levels of serum IgE [107,
110, 111]. Godfrey et al. suggest that this could be an
effect of a diminished population of Th-1 lymphocytes,
caused by impaired thymic maturation during a critical
period in fetal development, when other organs are pri-
oritized due to the ‘brain-sparing’ effect [107] (Fig. 1C).
It is possible that immunological mechanisms that can
normally be observed during the first year of life, such
Fig. 1. Fetal growth and maternal factors (A), placenta (B), umbilical cord and fetal factors (C) in relation to development of asthma, and allergic
disease in childhood (D) and adolescence (E).
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as a rapid suppression of Th2-responses in non-atopic
individuals and a consolidation of Th2-responses in
atopic individuals, are not fully developed due to
impaired fetal growth [112]. On the other hand, in a
study by Benn et al., neither the association between a
large head circumference and a small thymus, nor the
one between small thymus and allergic disease could be
confirmed [113].
Dysanapsis. One mechanism that has been much dis-
cussed is dysanapsis, the fact that airway size is not
necessarily related to lung size [114]. Mead et al.
found that the airways in adult men were 17% larger
than those in adult females [115]. Evidence for this
difference in size of airways between men and
women has recently been found by Sheel et al., who
used computer tomography to measure the respiratory
tree [116]. On comparing men and women matched
for lung size, women had significantly smaller airway
luminal areas. This knowledge of a gender-based dif-
ference in the lung composition is not yet known to
have a clinical implication for the development of
asthma, but may be part of the explanation why
asthma is overrepresented in boys but not in adult
men [117].
Catch-up growth and postnatal weight gain after fetal
growth restriction in association with asthma or
respiratory disease
Catch-up growth in childhood is a strong predictor of
non-communicable diseases in adulthood [13, 118,
119]. In a study by Hancox et al., those with the largest
weight gain between birth and the age of 3 years were
predisposed to an impaired lung diffusing capacity as
adults [13]. This is in line with a new theory that it is
the rapid catch-up growth following growth restriction
that causes the development of diseases later in life,
rather than fetal events [120] (Fig. 1D).
Although impaired fetal growth has an independent
effect on childhood asthma [35], postnatal weight gain
and obesity may also be causally involved in asthma
[121]. Lucas et al. registered birth weight and crown-
heel lengths in 131 normal-term infants [121], and then
measured their lung function at 5–14 weeks of age. In
univariate analyses, age-adjusted forced expiratory flow
at functional residual capacity was not related to birth
weight, but decreased by 11% per SD increase in infant
weight gain (P < 0.01). The respiratory rate rose by 5%
per SD increase in infant weight gain (P < 0.01). This is
in line with the concept of mismatch, where epigenetic
mechanisms have been suggested to play a role [122].
As a result of an interaction between genes and the
developing milieu during pregnancy, in the processes of
developmental plasticity, a fetus is being primed for the
predicted postnatal environment. This anticipated
environment might be mismatched with the actual post-
natal environment that the fetus encounters. When this
occurs the ability for an individual to react to environ-
mental encounters might be inadequate and increases
the risk of subsequent disease. The degree of mismatch
is therefore said to determine the individual’s predispo-
sition to chronic disease [123].
To study if infant weight gain patterns after birth
were associated with asthma development later in child-
hood, a randomized prospective study on 2-to-3-year-
old children at risk of asthma was performed in the
CARE network [124]. Birth weight, lung function,
growth and symptoms were noted. Weight gain patterns
were classified before study enrolment as decelerated,
average or accelerated. Participants then received either
inhaled corticosteroids or placebo for 2 years. After that
period medication was stopped and the children were
observed for one more year. Decelerated weight gain
patterns were found to be associated with fewer exacer-
bations (Fig. 1D).
A birth cohort study that investigated children at
birth and at the age of three found that the children in
the lowest birth weight group had an increased risk of
respiratory illness [125]. Children who started in the
lowest birth weight tertile and who were in the highest
weight tertile at age three had a higher risk than those
who remained in the middle group. Those with a high
BMI at 3 years of age also had an increased risk of
respiratory illness.
Most prospective studies on fetal growth follow
women from early pregnancy onwards. However, both
environmental and genetic factors are known to influ-
ence fetal growth and some of these factors might
change as the women become pregnant. To address this
problem, the Southampton Women’s Survey recruited
12 583 women between the ages of 20 and 34 years,
measured their characteristics pre-pregnancy, and fol-
lowed those who got pregnant and also their future
children [126]. Using this cohort Pike et al. found that
adipose weight gain after birth was associated with
both atopic and non-atopic wheezing [25]. This sup-
ports their theory that different growth rates during
pregnancy and after birth have an impact on a child’s
respiratory health.
Turner et al. studied the relationship between early
weight gain, lung function, formula feeding and early
asthma [127]. Children introduced to formula milk
before the age of 6 months grew more rapidly up to
age one than those given breast milk exclusively. Chil-
dren fed exclusively on breast milk had a lower preva-
lence of asthma at the age of 3 years than those who
received formula milk (OR 0.4; 95% CI 0.2–1.0,
P < 0.05). However at follow-up at the ages of 6 and
11 years this was no longer significant. It is possible
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that the weight gain of infants need to be more closely
monitored in the future, especially those at risk of
developing diseases (Fig. 1E).
Discussion
In conclusion, a low birth weight has been shown to be
associated with asthma [7–19, 125].
A high birth weight also predisposes for asthma
development, particularly when combined with a high
BMI later in life [31, 35]. Growth restriction followed
by a rapid catch-up growth has been shown to predis-
pose for impaired lung function and also for asthma
[13, 22, 25, 35, 121, 124, 125]. Theories differ whether
it is the actual fetal growth restriction in utero or the
rapid catch-up that predisposes for disease
development.
No studies investigating the correlation between birth
weight and future asthma have been randomized, dou-
ble-blinded controlled trials (RCT) due to the fact such
randomization is ethically and biologically impossible.
Most studies are based on data collected retrospectively
[7, 9, 11, 19, 24, 26, 29] or prospectively [8, 10, 13, 15,
16, 21, 22]. Retrospective study designs have collected
data about birth weight in different ways, such as regis-
ters or questionnaires [7, 9, 11, 19, 24, 26, 29]. There
are some inconsistent results between different popula-
tions. Reasons might include different outcomes, e g in
some studies the outcome is wheeze, in some asthma
diagnosis and in others asthma admission [24, 29–32].
In some studies the follow-up lasts to school age
whereas in others it lasts to adulthood. Study popula-
tion criteria, such as preterm and term children, size of
the cohort as well as methods of data collection, poten-
tial recall bias and selection, may also affect the results.
In addition, a given birth size can be the result of sev-
eral different antenatal growth trajectories, and thus an
infant born weighing 2.5 kg may be constitutively
small whereas another weighing 2.5 kg may have been
destined to be 3.5 kg and the latter may be at an
increased risk for asthma. Today, very few population-
based registers for longitudinal measures of growth are
available. For reasons of expediency or cost, large-scale
studies frequently use self-reported height and weight.
However, questions have arisen concerning the validity
of these measures, as some participants might over- or
underestimate their weight and height [128, 129]. Data
collection through parental questionnaires is another
common method within epidemiology. Questionnaire
data, however, can suffer from biases (such as misclas-
sification of exposure and recall bias) that decrease the
validity of the collected information and may
misrepresent the true association between two variables.
Since twins have the same gestational age and often
differ in birth weight [33] they are excellent for studies
on fetal growth. There might be some concern regard-
ing the generalizability of findings in twins to the gen-
eral population, because twins are generally more
growth restricted in utero than singletons [45]. For this
reason they may have higher rates of asthma later in
life. Nevertheless, some previous studies have shown
that twins have lower rates of asthma [130, 131],
whereas other studies have found no difference between
twins and singletons [132, 133].
When studying disease-discordant twins, these types
of confounding factors can be taken into account since
twins are generally brought up together and analyses
within-twin pairs control for unmeasured environmen-
tal and socio-economic factors during childhood.
Clinical relevance
Fetal growth retardation can be detected ultrasonically
and the fetus closely monitored until birth. Children at
risk can thus be identified early and followed over time
to receive proper medication early if symptoms
develop.
Future studies
To further understand the interplay between genetic
and environmental factors in childhood and adolescent
asthma and allergic disease, prospective studies should
be performed with well characterized subjects. A better
understanding of the effect of fetal growth is a key to
developing new diagnostic tools as well as prophylactic
interventions to reduce the burden of asthma and aller-
gic disease. Twin studies play an important role in the
detection of undiscovered genes, but may be even more
central in answering the most challenging of all ques-
tions: how the environment interacts with genetics in
these two outcomes. Future studies may also include
women from pre-pregnancy and follow them prospec-
tively during pregnancy and delivery, and follow the
offspring in early life, to ascertain measures of fetal
growth (anthropometric measures, cord blood and pla-
centa) in relation to subsequent asthma and allergic dis-
ease [126, 134]. This may lead to altered guidelines and
improved surveillance of children at risk.
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